C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.
about
Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in menJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Are statins anti-inflammatory?From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionNanotechnology in dentistry: prevention, diagnosis, and therapyC-reactive protein, antiinflammatory drugs, and quality of life in diabetesRole of C-reactive protein in cardiovascular diseaseC-reactive protein (CRP)-lowering agentsOngoing clinical trials of the pleiotropic effects of statinsCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseaseSocioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studiesLow-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillationHDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 productionThe vascular effects of infection in Pediatric Stroke (VIPS) Study.A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing.Recent advances in ischaemic heart disease.Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal populationProcoagulant factors and the risk of myocardial infarction in young women.Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis.Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction.Cardiac markers: present and future.Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder.Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infectionInfection and inflammation-induced proatherogenic changes of lipoproteins.High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneIdentifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.C-reactive Protein as a Predictor of Adverse outcome in Patients with Acute Coronary Syndrome.Human C-reactive protein and the metabolic syndrome.Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease.C-reactive Protein as Predict of Increased Carotid Intima Media Thickness in Patients with Chronic PeriodontitisNovel risk factors for stroke: homocysteine, inflammation, and infection.The renin angiotensin system as a risk factor for coronary artery disease.Perspectives on vascular biology and diabetes.Understanding cytokines. Part I: Physiology and mechanism of action.Understanding cytokines. Part II: Implications for nursing research and practice.Inflammatory mechanisms of stroke.The differential impact of subjective and objective aspects of social engagement on cardiovascular risk factorsMitral valve restenosis after percutaneous transmitral valvuloplasty, role of continuous inflammation
P2860
Q23918985-88B7E31B-C20B-44C9-812E-F4E9063EEB16Q24630160-BE1BD3EE-342D-4141-B308-7E0C6FF9EC80Q24792912-45BC80AA-55BD-4B40-82A5-098F05D1DCF9Q26770209-B5EF439F-D913-4C5B-A3C1-37084C40CEE2Q26778689-A8F74E21-ED02-4954-A885-803BC262E591Q28165737-57617BA3-5F87-405A-9916-E1BBCC63148FQ28166927-262EC7DB-4375-48D7-98A0-6034D690AE47Q28200344-0C85A3E5-C4B0-4CE6-8BCB-D7EB7627B683Q28219321-B3EFB5F7-322D-4D18-BE81-F03A4E4CBAF3Q28219483-BCFE90FB-E03F-43E3-BCA6-1C88A9B73AC0Q28219691-DF19D31A-D9F9-4E81-A52A-0FB42CE249F5Q28258399-BD117729-61EB-432A-AFB8-6039F130BF02Q28580308-0AE46F45-3234-4BF3-BCAE-E46038F903E6Q30425204-B8AB789F-1B5F-4B33-9EEF-150E65E3C7FAQ30494320-3FC5A008-D76E-4810-A7F7-16F7FFA5FF9BQ30912640-8F5B65CF-EFAD-4742-9FEE-6DB7EC09323AQ33323378-CBE5A93A-63B3-43EC-8803-8639978D6181Q33370819-E88F1477-53D1-4754-9B8F-0F022F058413Q33570509-81A0D334-05EF-47E2-8D92-A5AB63980066Q33691606-58CA9237-7F72-4AFD-A03E-3A7F85F85916Q33704714-7D691A89-1936-4ECA-B139-19EC4FBF64D6Q33788524-8DC3BF4D-D09D-408E-8AA3-C70B80E9C3C1Q33805731-DAF21291-1CB7-431C-BE96-DC8B480C0422Q33849312-317372E3-8CBD-43BA-9B30-D883969C74B6Q33907642-199FC5E8-CD6B-485E-A0EC-9DD4896D3081Q33935040-FCB92FD6-25F6-4A7C-8544-4E56A7030026Q33979763-74D06959-8EA7-4A3F-BB51-AE458FC360C6Q34030905-0FDE5D3E-FC9F-452D-942B-2447EE915F4FQ34032614-A5255219-56FA-4873-8BB7-C9AFBB6AA286Q34066540-163F5451-B110-4BF8-875B-8A8AE14CAD51Q34097321-421314EC-2DEF-4594-A144-D46E85FFF90CQ34106061-1AB67EF4-9658-4513-AB8A-B527AD575028Q34107356-B0033A33-3C60-4005-9C1A-ED42A1EFD0CAQ34140718-DCAB7D12-98A6-4F1E-A454-33165C5DBABAQ34161037-44F0185B-38C7-441A-A4A1-2C68A6883511Q34171362-2AD39DD6-7D35-43A2-9227-E670C24283A8Q34171367-2D384AA0-E052-49FF-A0F0-5B4356BB8954Q34235537-F9584968-C97B-42FF-ACBE-1237FD98915FQ34330933-1D4B60D5-5DC3-42E1-9C41-53CE8D618E12Q34333491-DEAA2BDC-74D1-48B7-947C-921D0DC3D128
P2860
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
C-reactive protein adds to the ...... f first myocardial infarction.
@en
type
label
C-reactive protein adds to the ...... f first myocardial infarction.
@en
prefLabel
C-reactive protein adds to the ...... f first myocardial infarction.
@en
P2093
P1433
P1476
C-reactive protein adds to the ...... f first myocardial infarction.
@en
P2093
P304
P356
10.1161/01.CIR.97.20.2007
P407
P577
1998-05-01T00:00:00Z